| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.079 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |